Newsfiscal.ai
Anavex Life Sciences Provides Corporate Update on Clinical Progress
· Published
Article summary
Anavex Life Sciences Corp. announced the completion of clinical conduct for its ADME and DDI studies and provided an update on its core blarcamesine development programs.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…